Brief: In8bio Presents T Cell Engager Data Demonstrating Deep B Cell Depletion For Autoimmune Indications
27/10/2025 13:29
Oct 27 (Reuters) - IN8bio Inc INAB.O: IN8BIO PRESENTS T CELL ENGAGER DATA DEMONSTRATING DEEP B CELL DEPLETION FOR AUTOIMMUNE INDICATIONS IN8BIO INC - INB-619 SHOWS EQUIVALENT EFFICACY TO FDA-APPROVED TCE COMPOUNDS Source text: ID:nGNX1RmHJZ Further company coverage: INAB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall